Bogart Wealth LLC’s Champions Oncology CSBR Stock Holding History

Bogart Wealth LLC’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-125	Closed	–	–	350
2017 Q4	$0	Hold	125	–	–	﹤0.01%	343
2017 Q3	$0	Buy	+125	New	+$383	﹤0.01%	331

Other funds holding CSBR

BPI

Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SKK

Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

SSB

Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bogart Wealth LLC's CSBR Position: Q1 2018 in Review

Bogart Wealth LLC sold out of Champions Oncology (CSBR) in Q1 2018, closing a stake of 125 shares.

Bogart Wealth LLC first reported a position in CSBR in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 14 funds tracked by Wall St. Rank hold CSBR as of Q1 2018.

Bogart Wealth LLC reported no remaining Champions Oncology position as of Q1 2018 after selling out during the quarter.
Bogart Wealth LLC sold 125 Champions Oncology shares in Q1 2018.
Bogart Wealth LLC first reported a position in Champions Oncology in Q3 2017 and held it in 2 quarters.
Bogart Wealth LLC's Champions Oncology position peaked at $0 in Q4 2017.
14 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2018.

Based on Bogart Wealth LLC's 13F filing for Q1 2018, filed 13 Apr 2018.